GVOKE HYPOPEN
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 12 May 2026)
What this means for you
Registered since 25 Aug 2020. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 25 Aug 2030: the §8 & §9 renewal).
Record
- Serial number
- 88011932
- Registration number
- 6136874
- Mark type
- Word mark
- Filed
- 22 Jun 2018
- Published for opposition
- 20 Nov 2018
- Registered
- 25 Aug 2020
- Next maintenance filing
- §8 & §9 renewal, due by 25 Aug 2030 (grace period to 25 Feb 2031)
- Attorney of record
- Tracy-Gene G. Durkin
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of diabetes and metabolic diseases; medical apparatus, namely, a drug delivery device prefilled with pharmaceutical products for the treatment of diabetes and metabolic diseases; pre-filled syringes and vials containing pharmaceutical preparations for the treatment of diabetes and metabolic diseases
Owner
- Xeris Pharmaceuticals, Inc., Chicago, IL, US
- Xeris Pharmaceuticals, Inc., Chicago, IL, US
- Xeris Pharmaceuticals, Inc., Chicago, IL, US
Board proceedings on this mark
The owner also pleads this mark in 1 other Board proceeding.
Prosecution history
- 12 May 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 12 May 2026 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 12 May 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 18 Feb 2026 — TEAS SECTION 8 & 15 RECEIVED
- 25 Aug 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 23 Jun 2022 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 19 May 2022 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 25 Aug 2020 — REGISTERED-PRINCIPAL REGISTER
- 24 Jul 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 23 Jul 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 23 Jul 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 02 Jul 2020 — USE AMENDMENT FILED
- 23 Jul 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 02 Jul 2020 — TEAS STATEMENT OF USE RECEIVED
- 22 May 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED